Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2012 1
2020 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
An open-source digital contact tracing system tailored to haulage.
Muwonge A, Wee BA, Mugerwa I, Nabunya E, Mpyangu CM, Bronsvoort BMC, Ssebaggala ER, Kiayias A, Mwaka E, Joloba M. Muwonge A, et al. Among authors: nabunya e. Front Digit Health. 2023 Jul 19;5:1199635. doi: 10.3389/fdgth.2023.1199635. eCollection 2023. Front Digit Health. 2023. PMID: 37538199 Free PMC article.
Prevalence of neural tube defects, maternal HIV status, and antiretroviral therapy from a hospital-based birth defect surveillance in Kampala, Uganda.
Barlow-Mosha L, Serunjogi R, Kalibbala D, Mumpe-Mwanja D, Williamson D, Valencia D, Tinker SC, Matovu JN, Moore CA, Adler MR, Nelson L, Nankunda J, Nabunya E, Birabwa-Male D, Musoke P. Barlow-Mosha L, et al. Among authors: nabunya e. Birth Defects Res. 2022 Feb;114(3-4):95-104. doi: 10.1002/bdr2.1964. Epub 2021 Nov 11. Birth Defects Res. 2022. PMID: 34766465 Free PMC article.
Overcoming staffing challenges when implementing a birth defects surveillance system: a Ugandan experience.
Namale-Matovu J, Barlow-Mosha L, Mumpe-Mwanja D, Kalibbala D, Serunjogi R, Nankunda J, Valencia D, Nabunya E, Byamugishat J, Birabwa-Male D, Okwero MA, Nolan M, Williamson D, Musoke P. Namale-Matovu J, et al. Among authors: nabunya e. J Glob Health Rep. 2020;4:10.29392/001c.12503. doi: 10.29392/001c.12503. J Glob Health Rep. 2020. PMID: 33851034 Free PMC article. No abstract available.
The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial).
Byamugisha J, Adero N, Kiwanuka TS, Nalwadda CK, Ntuyo P, Namagembe I, Nabunya E, Nakirijja E, Mwadime-Ngolo R, Mukasa DC, Ononge S. Byamugisha J, et al. Among authors: nabunya e. BMC Pregnancy Childbirth. 2022 Mar 3;22(1):179. doi: 10.1186/s12884-022-04507-3. BMC Pregnancy Childbirth. 2022. PMID: 35241006 Free PMC article. Clinical Trial.
Comparative analysis of perinatal outcomes and birth defects amongst adolescent and older Ugandan mothers: evidence from a hospital-based surveillance database.
Serunjogi R, Barlow-Mosha L, Mumpe-Mwanja D, Williamson D, Valencia D, Tinker SC, Adler MR, Namale-Matovu J, Kalibbala D, Nankunda J, Nabunya E, Birabwa-Male D, Byamugisha J, Musoke P. Serunjogi R, et al. Among authors: nabunya e. Reprod Health. 2021 Mar 4;18(1):56. doi: 10.1186/s12978-021-01115-w. Reprod Health. 2021. PMID: 33663555 Free PMC article.
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
Six Week Extended-Dose Nevirapine (SWEN) Study Team; Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S. Six Week Extended-Dose Nevirapine (SWEN) Study Team, et al. Lancet. 2008 Jul 26;372(9635):300-13. doi: 10.1016/S0140-6736(08)61114-9. Lancet. 2008. PMID: 18657709